{
  "docId": "019de071-3038-7429-b878-7396b16fa735",
  "docSlug": "1877638ec56f6991bfeb170acd78b19e",
  "documentTitle": "Teknova | IPO Presentation Deck | 35 slides",
  "authorId": "teknova",
  "authorName": "Teknova",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 30,
  "pageCount": 35,
  "prevPage": 29,
  "nextPage": 31,
  "slideType": "traction",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 8,
  "notes": "The chart is a donut chart showing revenue distribution between Lab Essentials and Clinical Solutions.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-3038-7429-b878-7396b16fa735/30",
  "deckHref": "/decks/019de071-3038-7429-b878-7396b16fa735",
  "deckJsonHref": "/decks/019de071-3038-7429-b878-7396b16fa735.json",
  "deckAnchorHref": "/decks/019de071-3038-7429-b878-7396b16fa735#slide-30",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.35,
        "x": 0.15,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Donut chart showing revenue segments: Lab Essentials ($21.2M, +17% y/y) and Clinical Solutions ($4.8M, +253% y/y), with a total of $27M* (+30% y/y).",
      "attrs": null,
      "subkind": "donut",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7dbc3e81-522c-4437-8091-e9110d85f41c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.35,
        "x": 0.58,
        "y": 0.25
      },
      "kind": "list",
      "text": "Key Highlights: Strong Lab Essentials (RUO) growth +17% y/y representing ~79% of Revenue; Clinical Solutions (GMP) up 253% y/y, representing ~18% of Revenue; Excludes $4.3M non-recurring revenue from Sample Transport related to COVID",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6045d4e6-3e0a-4cb3-a425-167ba39c7de5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.46,
        "y": 0.86
      },
      "kind": "source-note",
      "text": "* Excludes $4M of non-recurring COVID-19 Sample Transport revenue.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "48faee3e-3003-4c81-bfc5-16f0a3c00a03",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.4,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "2020 revenue segment detail",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a6cb77ab-db71-4140-992c-847060e34c75",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 31,
      "from": 29,
      "beatId": "e529b4fb-6a29-4fc3-b5d4-4adb3a11dd89",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Financials",
      "beatSlug": "sequoia-pitch-financials",
      "evidence": "Financials are presented on pages 29-31",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}